QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=3D6E4177C1A2C936A25F58E22CF119FE;jsessionid=345F3C3E31C12C444C4BFB6C7444F45F;jsessionid=BD9211D0409253AA8F0D3B430F1ADC06;jsessionid=FA979FF6DE873EBD7E5AC2E0DD2DEB1A;jsessionid=E1BB80C09086475ADB27119A3CDD32ED;jsessionid=A144B7133C93AF86845672E2C4C21A99 (gene)

1. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
2. Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggre…
3. The RNA-binding protein and stress granule component ATAXIN-2 is expressed in mouse and human tissue…
4. Ataxin-2 gene: a powerful modulator of neurological disorders.
5. Antagonistic roles for Ataxin-2 structured and disordered domains in RNP condensation.

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=3D6E4177C1A2C936A25F58E22CF119FE;jsessionid=345F3C3E31C12C444C4BFB6C7444F45F;jsessionid=BD9211D0409253AA8F0D3B430F1ADC06;jsessionid=FA979FF6DE873EBD7E5AC2E0DD2DEB1A;jsessionid=E1BB80C09086475ADB27119A3CDD32ED;jsessionid=A144B7133C93AF86845672E2C4C21A99